{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ChromaDex Corporation"},"Symbol":{"label":"Symbol","value":"CDXC"},"Address":{"label":"Address","value":"10900 WILSHIRE BOULEVARD,SUITE 600, LOS ANGELES, California, 90024, United States"},"Phone":{"label":"Phone","value":"+1 310 388-6706"},"Industry":{"label":"Industry","value":" Medicinal Chemicals and Botanical Products "},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors."},"CompanyUrl":{"label":"Company Url","value":"https://www.chromadex.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Robert N. Fried","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}